Clinical Trial Update: The ICON Study: Outcomes After FMT for Patients With IBD and CDI [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates for the ICON Study examining outcomes after fecal microbiota transplantation in patients with inflammatory bowel disease and Clostridium…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection
• Inflammatory Bowel Disease

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Inflammatory Bowel Diseases, Clostridium Difficile Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-09-21